Top T1D BSR This Week - Episode 43 - GLP-1 and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal?; Piras et al

T1D Cutting Edge Research - Episode 45 - The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs; Spurrell et al.

In the forty-fifth episode of "Type 1 Diabetes: Cutting Edge Research" we discuss the paper In the forty-third episode of "Type 1 Diabetes: Cutting Edge Research" we discuss the paper The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs. ciT1zen science from the(sugar)science is devoted to helping the entire Type 1 Diabetes (T1D) community become more familiar with cutting edge science happening now. Podcasts and summaries to keep you informed. We curate and share important T1D science that you can understand, follow and enjoy. Please note that podcasts were created with the help of notebookLM.

Top T1D BSR This Week - Episode 44 - 3D imaging of an entire pancreas shows inverse proportions of extra-islet versus islet-associated β cells in late-onset type 1 diabetes; Lehrstrand et al

In the forty-forth episode of "Top Type 1 Diabetes Basic Science Research This Week" we discuss the paper Titled 3D imaging of an entire pancreas shows inverse proportions of extra-islet versus islet-associated β cells in late-onset type 1 diabetes. ciT1zen science from the(sugar)science is devoted to helping the entire Type 1 Diabetes (T1D) community become more familiar with cutting edge science happening now. Podcasts and summaries to keep you informed. We curate and share important T1D science that you can understand, follow and enjoy.

Top T1D CR This Week - Episode 46 - The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs; Sun et al

In the forty-sixth episode of "Top Type 1 Diabetes Clinical Research This Week" we discuss the paper In the forty-fifth episode of "Top Type 1 Diabetes Clinical Research This Week" we discuss the paper The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs. ciT1zen science from the(sugar)science is devoted to helping the entire Type 1 Diabetes (T1D) community become more familiar with cutting edge science happening now. Podcasts and summaries to keep you informed. We curate and share important T1D science that you can understand, follow and enjoy. Please note that podcasts were created with the help of notebookLM. . ciT1zen science from the(sugar)science is devoted to helping the entire Type 1 Diabetes (T1D) community become more familiar with cutting edge science happening now. Podcasts and summaries to keep you informed. We curate and share important T1D science that you can understand, follow and enjoy. Please note that podcasts were created with the help of notebookLM.

Top T1D BSR This Week - Episode 43 - GLP-1 and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal?; Piras et al

In the forty-third episode of "Top Type 1 Diabetes Basic Science Research This Week" we discuss the paper Titled Going From Stage 2 to Stage 3 Type 1 Diabetes—Does Not Matter How You Got Here. ciT1zen science from the(sugar)science is devoted to helping the entire Type 1 Diabetes (T1D) community become more familiar with cutting edge science happening now. Podcasts and summaries to keep you informed. We curate and share important T1D science that you can understand, follow and enjoy.

Top T1D BSR This Week - Episode 42 - Going From Stage 2 to Stage 3 Type 1 Diabetes—Does Not Matter How You Got Here; Jacobsen et al

In the forty-second episode of "Top Type 1 Diabetes Basic Science Research This Week" we discuss the paper Titled Going From Stage 2 to Stage 3 Type 1 Diabetes—Does Not Matter How You Got Here. ciT1zen science from the(sugar)science is devoted to helping the entire Type 1 Diabetes (T1D) community become more familiar with cutting edge science happening now. Podcasts and summaries to keep you informed. We curate and share important T1D science that you can understand, follow and enjoy.